Muhammad Sardar

644 total citations
38 papers, 312 citations indexed

About

Muhammad Sardar is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Muhammad Sardar has authored 38 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 10 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Muhammad Sardar's work include Atrial Fibrillation Management and Outcomes (6 papers), Cardiac Imaging and Diagnostics (5 papers) and Cardiovascular Function and Risk Factors (5 papers). Muhammad Sardar is often cited by papers focused on Atrial Fibrillation Management and Outcomes (6 papers), Cardiac Imaging and Diagnostics (5 papers) and Cardiovascular Function and Risk Factors (5 papers). Muhammad Sardar collaborates with scholars based in United States, Sweden and Pakistan. Muhammad Sardar's co-authors include Ronald Zolty, Jeremy A. Mazurek, Muhammad Chaudhry, Peter R. Kowey, Benjamin D. Horne, Karl Swedberg, Christopher M. O’Connor, Mustafa Toma, Justin A. Ezekowitz and Adrian F. Hernandez and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Muhammad Sardar

34 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muhammad Sardar United States 11 183 70 54 48 45 38 312
Ramya Mosarla United States 10 179 1.0× 62 0.9× 72 1.3× 76 1.6× 39 0.9× 20 341
Amir Aziz United Kingdom 11 101 0.6× 70 1.0× 91 1.7× 33 0.7× 32 0.7× 32 286
Lütfi Öcal Türkiye 10 147 0.8× 76 1.1× 75 1.4× 65 1.4× 23 0.5× 50 355
José Luis Zamorano Spain 13 290 1.6× 77 1.1× 75 1.4× 15 0.3× 47 1.0× 41 458
Georg Schlachtenberger Germany 9 95 0.5× 81 1.2× 88 1.6× 37 0.8× 10 0.2× 49 257
Mirta Koželj Slovenia 13 315 1.7× 100 1.4× 110 2.0× 45 0.9× 45 1.0× 42 468
Isabelle Amigues United States 11 58 0.3× 47 0.7× 16 0.3× 37 0.8× 36 0.8× 21 293
Matteo Casale Italy 9 141 0.8× 26 0.4× 24 0.4× 26 0.5× 26 0.6× 28 262
Reto Kurmann United States 12 155 0.8× 80 1.1× 72 1.3× 23 0.5× 14 0.3× 40 345
Javier León Jiménez Spain 9 159 0.9× 89 1.3× 70 1.3× 8 0.2× 32 0.7× 27 305

Countries citing papers authored by Muhammad Sardar

Since Specialization
Citations

This map shows the geographic impact of Muhammad Sardar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Sardar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Sardar more than expected).

Fields of papers citing papers by Muhammad Sardar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Sardar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Sardar. The network helps show where Muhammad Sardar may publish in the future.

Co-authorship network of co-authors of Muhammad Sardar

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Sardar. A scholar is included among the top collaborators of Muhammad Sardar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Sardar. Muhammad Sardar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sardar, Muhammad, et al.. (2021). Management of Relapsed Hairy Cell Leukemia: A Systematic Review of Novel Agents and Targeted Therapies. Clinical Lymphoma Myeloma & Leukemia. 21(10). 659–666. 2 indexed citations
2.
Sardar, Muhammad, et al.. (2021). A Systematic Review of the Role of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in the Treatment of Solid Tumors. Cureus. 13(4). e14494–e14494. 12 indexed citations
3.
Sardar, Muhammad, et al.. (2020). The Perspective of a Breast Cancer Patient: A Survey Study Assessing Needs and Expectations. Cureus. 12(7). e9171–e9171. 3 indexed citations
4.
Iqbal, Farrukh, et al.. (2019). GEMCITABINE INDUCED CARDIOMYOPATHY. Journal of the American College of Cardiology. 73(9). 2187–2187. 1 indexed citations
5.
Sardar, Muhammad, Saad Ullah Malik, Ali Younas Khan, et al.. (2019). Efficacy of Ibrutinib-Based Regimen in Chronic Lymphocytic Leukemia: A Systematic Review. Journal of Hematology. 8(1). 1–10. 4 indexed citations
6.
Sardar, Muhammad, et al.. (2018). Impact of Storage Lesion on Post-transfusion Rise in Hemoglobin. Cureus. 10(7). e2952–e2952. 1 indexed citations
7.
Chaudhry, Muhammad, et al.. (2018). TAKOTSUBO CARDIOMYOPATHY IN HUMAN IMMUNODEFICIENCY VIRUS POSITIVE PATIENTS: NATIONAL INPATIENT SAMPLE BASED RETROSPECTIVE REVIEW. Journal of the American College of Cardiology. 71(11). A716–A716. 1 indexed citations
8.
Sardar, Muhammad, et al.. (2017). Takotsubo cardiomyopathy: Pathophysiology and role of cardiac biomarkers in differential diagnosis. World Journal of Cardiology. 9(9). 723–730. 26 indexed citations
9.
Chaudhry, Muhammad & Muhammad Sardar. (2017). Vascular complications of transcatheter aortic valve replacement: A concise literature review. World Journal of Cardiology. 9(7). 574–574. 18 indexed citations
10.
Saeed, Fahad, Muhammad Sardar, & Timothy E. Quill. (2017). Racial Disparities in End-of-Life Care Knowledge and Treatment Preferences in Maintenance Dialysis Patients (S767). Journal of Pain and Symptom Management. 53(2). 447–447. 2 indexed citations
11.
Khan, Z, et al.. (2016). Ventricular fibrillation with intracoronary adenosine during fractional flow reserve assessment. Cardiovascular revascularization medicine. 17(7). 487–489. 3 indexed citations
12.
Burke, James, et al.. (2016). AParadigm Shift: The New Novel Oral Anticoagulation Agents.. PubMed. 26(7). 611–9.
13.
Sardar, Muhammad, et al.. (2014). A Long-Kept Secret in the Heart. Journal of the American College of Cardiology. 63(13). e27–e27.
14.
Sardar, Muhammad, et al.. (2014). Antiarrhythmic Drug Therapy for Atrial Fibrillation. Cardiology Clinics. 32(4). 533–549. 7 indexed citations
15.
Sardar, Muhammad, et al.. (2014). Recurrent right ventricular cardiac myxoma in a patient with Carney complex: a case report. Journal of Medical Case Reports. 8(1). 134–134. 9 indexed citations
16.
Sardar, Muhammad, et al.. (2014). INCIDENCE OF POSTOPERATIVE ATRIAL FIBRILLATION (POAF) AFTER ROBOTIC CABG VERSUS TRADITIONAL CABG AND ITS ASSOCIATED MORTALITY AND MORBIDITY. Journal of the American College of Cardiology. 63(12). A431–A431. 2 indexed citations
17.
Toma, Mustafa, Justin A. Ezekowitz, Jeffrey A. Bakal, et al.. (2013). The Relationship between Left Ventricular Ejection Fraction and Mortality in Patients with Acute Heart Failure: Insights from the ASCEND-HF Trial. European Journal of Heart Failure. 16(3). 334–341. 52 indexed citations
18.
Badri, Marwan, et al.. (2012). Isolated posteromedial papillary muscle endocarditis. European Heart Journal - Cardiovascular Imaging. 13(7). 630–630. 2 indexed citations
19.
Sardar, Muhammad, et al.. (2011). Abstract 16034: Affect of Warfarin on Long Term Pulmonary Arterial Hypertension (PAH) Mortality: Change of facts?. Circulation. 124. 3 indexed citations
20.
Sardar, Muhammad, et al.. (2011). Affect of Warfarin on Pulmonary Arterial Hypertension (PAH) Mortality: Facts Have Changed?. Journal of Cardiac Failure. 17(8). S66–S66. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ramya Mosarla Breakdown of academic impact, for papers by Amir Aziz Breakdown of academic impact, for papers by Lütfi Öcal Breakdown of academic impact, for papers by José Luis Zamorano Breakdown of academic impact, for papers by Georg Schlachtenberger Breakdown of academic impact, for papers by Mirta Koželj Breakdown of academic impact, for papers by Isabelle Amigues Breakdown of academic impact, for papers by Matteo Casale Breakdown of academic impact, for papers by Reto Kurmann Breakdown of academic impact, for papers by Javier León Jiménez
Rankless by CCL
2026